This appointment reflects a shared mission with Lucid Group to transform lives by ensuring innovative medicine doesn't stop at approval but reaches the patients who need it most. His leadership marks ...

Lucid Group, a leader in healthcare communications and commercialisation, has announced that Rod MacKenzie, former Executive Vice President and Chief Development Officer at Pfizer, has been appointed ...

Roger Dansey, M.D., a former senior executive at Pfizer and Seagen, brings extensive experience in oncology clinical development and the development of antibody-drug conjugates (ADCs) and other ...